13 hours ago
1
BeeBright
An EU pharma lobby has criticized the Trump administration’s plans to impose 15% tariffs on pharmaceutical imports amid uncertainty over how the newly announced U.S.-EU trade deal targets the product group, which has historically avoided levies due to public health
English (US) ·